Search results

{{Adrenergic receptor modulators}} {{Dopamine receptor modulators}} ...

...ABA receptor agonist|agonists]], [[GABA receptor antagonist|antagonists]], modulators, reuptake inhibitors and enzymes.<ref name="Froestl2011">{{cite journal|las * [[Adrenergic]] ...

...to vasoconstriction by interacting with cell surface [[Adrenergic receptor|adrenergic receptors.]]<ref>{{cite web|title = Isometheptene|url = http://www.drugbank {{Adrenergic receptor modulators}} ...

...(psychology)|mood]] regulation,<ref name="Julien2004" /> notably [[5-HT1A receptor|5-HT_1A]]-mediated transmission.<ref name="HalesShahrokh2009">{{c ...e A, Brocco M, Loiseau F, etal | title = S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: II ...

...all TCAs, TeCAs have only low affinity for the [[muscarinic acetylcholine receptor]]s, and for this reason, are associated with few or no [[anticholinergic]] ...y constant}}, {{abbr|nM|nanomolar}}) for various [[receptor (biochemistry)|receptor]]s and [[membrane transport protein|transporter]]s are as follows:<ref name ...

| class2 = [[Beta2-adrenergic receptor agonist|Short-acting β2-adrenergic agonist]] ...lbutamol]] (albuterol, a [[beta2-adrenergic receptor agonist|β₂-adrenergic agonist]]).<ref name="Combivent FDA label"/> ...

{{Adrenergic receptor modulators}} {{Dopamine receptor modulators}} ...

{{Acetylcholine metabolism and transport modulators}} {{Adrenergic receptor modulators}} ...

! Receptor !! K_i (nM) !! Notes | [[5-HT1A receptor|5-HT_1A]] || 17.3 || ...

...gonist]] and a weak [[Alpha-1 adrenergic receptor|α₁ adrenergic receptor]] agonist.{{cn|date=May 2019}} ...eptors. Apraclonidine is useful in this case due to its weak α₁-adrenergic properties. When applied to the denervated (and thus hyper-sensitive) pupil ...

.../sub>-adrenergic receptor]], and [[histamine]] [[H1 receptor|H₁ receptor]].{{Citation needed|date=July 2022}} ...eater activity at the 5-HT_2A receptor than at the D₂ receptor. This may explain the lack of [[extrapyramidal effects]] with propiomazine. ...

...r|5-HT_1A]] and [[5-HT1B receptor|5-HT_1B receptor]] [[receptor antagonist|antagonist]] in addition to being a beta blocker.<ref name="pmid {{Adrenergic receptor modulators}} ...

...a result of [[overdose]] with certain [[5-HT2A receptor|5-HT_2A receptor]] [[agonist]] drugs such as [[25I-NBOMe]],<ref>{{Cite web|title=Human Metab {{Adrenergic receptor modulators}} ...

...yons KE | title = Transdermal rotigotine: a clinically innovative dopamine-receptor agonist for the management of Parkinson's disease | journal = Pharmacothera ...ke receptor|D₁-like]] and [[D2-like receptor|D₂-like receptor]]s is similar to the case of [[apomorphine]] (which notably has greater [[e ...

...rgic agonist|alpha agonist]] that is selective to the [[alpha-2 adrenergic receptor]]. Guanabenz is used as an [[antihypertensive]] drug used in the treatment {{Adrenergic receptor modulators}} ...

{{Adrenergic receptor modulators}} {{Dopamine receptor modulators}} ...

...WH, Covey S | year = 1990 | title = Penbutolol and carteolol: two new beta-adrenergic blockers with partial agonism | journal = Journal of Clinical Pharmacology ...imetic drug]] with properties allowing it to act as a partial agonist at β adrenergic receptors.<ref name=Frishman/> ...

...It is a [[sympathomimetic]] agent with marked [[Adrenergic receptor|alpha adrenergic]] activity that acts on alpha-receptors in the [[arterioles]] of the [[conj ...₁-]] and [[alpha-2 adrenergic receptor|α₂-adrenergic receptor]] [[agonist]].<ref name="pmid32801982">{{cite journal | vauthors = Hosten L ...

{{Adrenergic receptor modulators}} {{Dopamine receptor modulators}} ...

{{Adrenergic receptor modulators}} ...